Qiu-Yan Chen

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial

Sai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang et al. · The Lancet Oncology · 2024 · 54 citations · Full text

Medicine, Oncology, Oncologic Surgery +11

Tislelizumab versus placebo combined with induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant tislelizumab or placebo for locoregionally advanced nasopharyngeal carcinoma: Interim analysis of a multicenter, randomized, placebo-controlled, double-blind, phase 3 trial.

Hai‐Qiang Mai, Sai Lan Liu, Qiu-Yan Chen et al. · Journal of Clinical Oncology · 2024 · 13 citations

Medicine, Oncology, Pharmacology +11

Reduced-dose radiotherapy for pretreatment EBV DNA selected low-risk stage III nasopharyngeal carcinoma: A single-arm, phase II trial.

Hai‐Qiang Mai, Jin-Hao Yang, Shanshan Guo et al. · Journal of Clinical Oncology · 2022 · 12 citations

Medicine, Oncology, Radiation Oncology +10